HFE and hemochromatosis type 1: As reported previously (Miranda et al., 2003; Sukumaran et al., 2017), cardiac iron levels were elevated by acute DOX treatment and in hemochromatosis and were highest in DOX-treated Hfe−/− mice (Figure 5B).